Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 184,508 | 95,229 | 118,285 | 80,077 | 247,393 |
| Marketable Securities | 114,037 | 200,753 | 175,489 | 184,194 | 137,686 |
| Receivables | 36,521 | 43,102 | 15,529 | 4,017 | 2,975 |
| Inventories | 2,904 | 3,229 | 9,006 | 6,831 | 3,973 |
| TOTAL | $341,392 | $343,955 | $320,207 | $276,948 | $394,186 |
| Non-Current Assets | |||||
| PPE Net | 60,535 | 71,239 | 80,723 | 76,825 | 39,448 |
| Investments And Advances | 18,109 | 52,930 | 72,792 | 30,975 | 53,304 |
| Other Non-Current Assets | 3,465 | 4,984 | 5,833 | 6,826 | 8,459 |
| TOTAL | $82,109 | $129,153 | $159,348 | $114,626 | $101,211 |
| Total Assets | $423,501 | $473,108 | $479,555 | $391,574 | $495,397 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,337 | 18,872 | 18,933 | 30,309 | 14,830 |
| TOTAL | $40,357 | $34,139 | $72,923 | $40,118 | $22,022 |
| Non-Current Liabilities | |||||
| Long Term Debt | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 |
| Deferred Revenues | 17,020 | 15,267 | 40,173 | 9,659 | 6,766 |
| Other Non-Current Liabilities | 0 | 0 | 159 | 0 | 0 |
| TOTAL | $269,142 | $256,426 | $268,989 | $205,475 | $207,020 |
| Total Liabilities | $309,499 | $290,565 | $341,912 | $245,593 | $229,042 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,859 | 56,122 | 55,563 | 44,503 | 43,964 |
| Common Shares | 56 | 56 | 55 | 44 | 44 |
| Retained earnings | -585,280 | -489,834 | -531,533 | -424,075 | -299,698 |
| Other shareholders' equity | -785 | -3,068 | -3,997 | -3,172 | -1,615 |
| TOTAL | $114,002 | $182,543 | $137,643 | $145,981 | $266,355 |
| Total Liabilities And Equity | $423,501 | $473,108 | $479,555 | $391,574 | $495,397 |